3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
2709
Lung Neoplasms
2269
Small Cell Lung Carcinoma
452
Breast Neoplasms
394
Neoplasms
348
Colorectal Neoplasms
245
Ovarian Neoplasms
208
Pancreatic Neoplasms
196
Melanoma
196
Prostatic Neoplasms
187
Adenocarcinoma of Lung
184
Neoplasm Metastasis
177
Head and Neck Neoplasms
175
Mesothelioma, Malignant
152
Esophageal Neoplasms
144
Carcinoma, Renal Cell
142
Stomach Neoplasms
141
Colonic Neoplasms
138
Urinary Bladder Neoplasms
124
Mesothelioma
121
Squamous Cell Carcinoma of Head and Neck
115
Uterine Cervical Neoplasms
97
Brain Neoplasms
87
Sarcoma
86
Kidney Neoplasms
82
Carcinoma, Hepatocellular
71
Liver Neoplasms
68
Adenocarcinoma, Bronchiolo-Alveolar
68
Rectal Neoplasms
64
Pleural Effusion, Malignant
64
Interventions
Vinorelbine
1
Gemcitabine
1
Drug Therapy
1
Cisplatin
1
Cilengitide
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Metatropic dwarfism
×
Thoracic
×
Clear all
NCT00842712
2017-01-13
CERTO
Merck KGaA, Darmstadt, Germany
Phase 2
Completed
232 enrolled
17 charts